DENV antibody (pan)

Catalog No. ABIN180831

Product Details anti-DENV Antibody

Target: DENV (Dengue Virus (DENV))

Binding Specificity: pan

Reactivity: Dengue Virus

Host: Mouse

Clonality: Monoclonal

Conjugate: This DENV antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Purification: Affinity Chromatography on Protein A

Clone: Dengue 1-11(3)

Isotype: IgG2a

Application Details

Application Notes: ELISA. Western Blot (Reducing Conditions). Immunohistochemistry on Paraffin Sections: Requires antigen retrieval using heattreatment prior to staining of paraffin Sections (Sodium citrate buffer pH 6.0 isrecommended for this purpose).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Concentration: 1.0 mg/mL

Buffer: PBS, pH 7.2, 0.05 % Sodium Azide

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Expiry Date: 12 months

Target Details for DENV

Target: DENV (Dengue Virus (DENV))

Alternative Name: Dengue Virus (DENV Products)

Target Type: Virus

Background: The dengue virus is responsible for the tropical and sub-tropical diseases, dengue (DF) and dengue haemorrhagic fever (DHF), transmitted to individuals through the bite of the Aedes mosquito. The global distribution of dengue is expanding and comparable to that of malaria, with symptoms ranging from a mild viral syndrome of high fever, rash, headache, fatigue and muscle and joint pain, to the more severe and sometimes fatal DHF. Each dengue virus serotype is antigenically distinct, such that infection only provides an individual with immunity to the causative serotype, with the possibility of further infection by a different serotype or even multiple serotypes.